[A case of acute cholestatic hepatitis associated with Orlistat].
Year: 2002
Type: article
Study design: Case Report
Abstract: Orlistat(Xenical(R), Roche) is considered a safe and effective drug to treat obesity by reduced absorption of 30% digested fat. To date, no serious adverse effects affecting the liver have been published except a case of subacute hepatic failure leading to liver transplantation in a young women with moderate obesity treated with orlistat. We report a case of acute cholestatic hepatitis in a young woman with moderate obesity treated with orlistat: a 33-year-old female admitted for the evaluation of jaundice. Abdominal ultrasonography, ERCP, routine chemistry, viral markers, and a fine needle biopsy of liver were performed. Microscopic findings of the liver biopsy specimen were compatible with acute cholestatic hepatitis. After steroid therapy, liver function was improved.
Source: PubMed
Authors: Doh Hyun Kim, Eun Hee Lee, Jae Chul Hwang, Jai Hak Jeung, Do Hyun Kim, Jae Youn Cheong, Sung Won Cho, Young Bae Kim
Institution: Ajou University
Language: Korean
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W2417755779
